Nursing care plan

Infections after surgery are more likely due to bacteria already on your skin than from microbes in the hospital − new research

Retrieved on: 
Wednesday, April 10, 2024

Genetic data from the bacteria causing these infections – think CSI for E. coli – tells another story: Most health care-associated infections are caused by previously harmless bacteria that patients already had on their bodies before they even entered the hospital.

Key Points: 
  • Genetic data from the bacteria causing these infections – think CSI for E. coli – tells another story: Most health care-associated infections are caused by previously harmless bacteria that patients already had on their bodies before they even entered the hospital.
  • We show that many surgical site infections after spinal surgery are caused by microbes that are already on the patient’s skin.

Surgical infections are a persistent problem

  • Among the different types of heath care-associated infections, surgical site infections stand out as particularly problematic.
  • A 2013 study found that surgical site infections contribute the most to the annual costs of hospital-acquired infections, totaling over 33% of the US$9.8 billion spent annually.
  • Still, surgical site infections occur following about 1 in 30 procedures, typically with no explanation.
  • While rates of many other medical complications have shown steady improvement over time, data from the Agency for Healthcare Research and Quality and the Centers for Disease Control and Prevention show that the problem of surgical site infection is not getting better.

BYOB (Bring your own bacteria)

  • Prior studies on surgical site infection have been limited to a single species of bacteria and used older genetic analysis methods.
  • But new technologies have opened the door to studying all types of bacteria and testing their antibiotic resistance genes simultaneously.
  • Over a one-year period, we sampled the bacteria living in the nose, skin and stool of over 200 patients before surgery.
  • In fact, 86% of the bacteria causing infections after spine surgery were genetically matched to bacteria a patient carried before surgery.
  • That number is remarkably close to estimates from earlier studies using older genetic techniques focused on Staphylococcus aureus.
  • They likely acquired these antibiotic-resistant microbes through prior antibiotic exposure, consumer products or routine community contact.

Preventing surgical infections

  • At face value, our results may seem intuitive – surgical wound infections come from bacteria that hang out around that part of the body.
  • If the most likely source of surgical infection – the patient’s microbiome – is known in advance, this presents medical teams with an opportunity to protect against it prior to a scheduled procedure.
  • The fact that most infections don’t actually start with sources in the hospital is probably a testament to the efficacy of these protocols.


Dustin Long receives funding from the National Institutes of Health. Dr Bryson-Cahn receives funding from the Gordon and Berry Moore Foundation and is the co-medical director for Alaska Airlines.

New Study Finds AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration and Significantly Reduce False Alarms for Clinicians

Retrieved on: 
Tuesday, April 9, 2024

The prediction models used in the study are a part of CLEW’s intelligent clinical surveillance platform.

Key Points: 
  • The prediction models used in the study are a part of CLEW’s intelligent clinical surveillance platform.
  • It also supports the health system with capacity management, by providing early identification of potential bottlenecks caused by unexpected deterioration.
  • In addition to demonstrating its superior accuracy, the study concluded that the CLEW system generated 50-times fewer alarms than other leading systems.
  • In busy and overburdened critical care environments, this can greatly reduce alarm fatigue and the associated cognitive burden on caregivers.

TGH Women's Institute Receives Highest Honor from National Accrediting Body

Retrieved on: 
Friday, April 5, 2024

TAMPA, Fla., April 5, 2024 /PRNewswire/ -- The Women's Institute at Tampa General Hospital (TGH) announced that it has received the highest national designation (Level IV) in maternal care from The Joint Commission — the gold standard in accreditation — underscoring its commitment to excellence in care for mothers and babies.

Key Points: 
  • The Joint Commission, a nonprofit organization dedicated to empowering health care organizations in providing the highest level of safety and quality, verified the TGH Women's Institute as a Level IV Maternal Care hospital.
  • Founded in 1951, The Joint Commission is the nation's oldest and largest standards-setting and accrediting body in health care.
  • The TGH Women's Institute provides a full range of women's health services, from routine obstetrics and gynecology to more complex maternal-fetal medicine and neonatal care.
  • The Institute is one of only 11 health care facilities in Florida and the only one in Hillsborough County to receive this distinction.

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Thursday, March 21, 2024

Revenues for the fourth quarter of 2023 were $2.69 million, up 89%, compared to $1.42 million in the fourth quarter of 2022.

Key Points: 
  • Revenues for the fourth quarter of 2023 were $2.69 million, up 89%, compared to $1.42 million in the fourth quarter of 2022.
  • Gross margin for the fourth quarter of 2023 was $1.03 million, compared to $0.30 million in the fourth quarter of 2022.
  • Research and development expenses for the fourth quarter of 2023 were $5.96 million, compared to $5.22 million in the fourth quarter of 2022.
  • Sales, marketing, general, and administrative expenses for the fourth quarter of 2023 were $6.70 million, compared to $8.71 million in the fourth quarter of 2022.

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

Retrieved on: 
Monday, March 18, 2024

We have never been more focused on our mission and goals. Every team member at Daxor sees both the remarkable strides the company has made over the past year solidifying its position as the global leader in blood volume measurement technology and the promise of what our rapid expansion means for both the company and the tens of millions of patients whose care we are eager to significantly improve. In every area 2023 and the strong start of 2024 has shown substantial progress for the company -- in revenue growth, new customer acquisitions, increasing utilization of our products by existing customers, next generation systems completed and under Food and Drug Administration (FDA) review, positive clinical studies, new patents granted and pending, successful National Institutes of Health (NIH) grant awards, Department of Defense (DoD) contracts awarded, and further research and development for groundbreaking products set to launch in subsequent fiscal years. I will detail below more in these areas but first wish to review why our company’s mission to commercialize the products that enable optimal patient care is so vital.

Key Points: 
  • Oak Ridge, TN, March 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology today issued a corporate update in a Letter to Shareholders filed in its certified shareholder report on Form N-CSR on March 15, 2023 from CEO & President, Michael Feldschuh.
  • Many of these markers are costly, some are invasive, and none are accurate – in contrast to Daxor’s proven 98% accurate system.
  • Care teams cannot effectively treat what they do not correctly diagnose, so our rapid accurate diagnostic test is a game-changer.
  • Daxor has been reporting as an investment company under the Investment Company Act of 1940 since January 1, 2012.

Air Methods Ascend Receives American Nurses Credentialing Center Accreditation

Retrieved on: 
Tuesday, March 12, 2024

GREENWOOD VILLAGE, CO, March 12, 2024 (GLOBE NEWSWIRE) -- Air Methods , the nation’s leading air medical service provider, announced its nationwide clinical training program is now accredited by the American Nurses Credentialing Center (ANCC).

Key Points: 
  • GREENWOOD VILLAGE, CO, March 12, 2024 (GLOBE NEWSWIRE) -- Air Methods , the nation’s leading air medical service provider, announced its nationwide clinical training program is now accredited by the American Nurses Credentialing Center (ANCC).
  • This accreditation encompasses Ascend’s Critical Care Readiness in-person training and Critical Care Review online modules and is a testament to the clinical quality Air Methods Ascend not only provides its own clinicians but to clinicians nationwide.
  • This accreditation not only validates the quality of our program but also reinforces our position as a leader in the field of air medical services,” said Air Methods Senior Vice President of Clinical Services Dr. Stephanie Queen.
  • “The ANCC accreditation elevates Air Methods Ascend and helps to set us apart in the industry,” said Air Methods Ascend Clinical Education Manager Jeff Simons.

Galectin Therapeutics Expands Clinical Team with the Appointment of Khurram Jamil, M.D. as Vice President, Clinical Development

Retrieved on: 
Tuesday, March 12, 2024

NORCROSS, Ga., March 12, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced the appointment of Khurram Jamil, M.D.

Key Points: 
  • NORCROSS, Ga., March 12, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced the appointment of Khurram Jamil, M.D.
  • as Vice President, Clinical Development.
  • Dr. Jamil brings to Galectin almost two decades of experience in clinical development across the biotechnology industry.
  • “We are pleased to welcome Khurram to the Galectin team at such a meaningful time of our development program” said Pol F. Boudes, M.D., Chief Medical Officer.

Study Evaluates Prevalence of Four Recommended Practices for Suicide Prevention Following Hospital Discharge

Retrieved on: 
Tuesday, March 12, 2024

A new study , funded by Pew Charitable Trusts, in The Joint Commission Journal on Quality and Patient Safety (JQPS), evaluated the prevalence of four suicide prevention activities following hospital discharge among Joint Commission-accredited hospitals:

Key Points: 
  • A new study , funded by Pew Charitable Trusts, in The Joint Commission Journal on Quality and Patient Safety (JQPS), evaluated the prevalence of four suicide prevention activities following hospital discharge among Joint Commission-accredited hospitals:
    While these specific suicide prevention activities are not explicitly required by The Joint Commission’s National Patient Safety Goal (NPSG), they are recommended by many suicide prevention experts.
  • By understanding the adoption of recommended practices for suicide prevention, hospitals can help improve care for people at risk and save lives.”
    Researchers calculated the percentage of hospitals reporting the implementation of these recommended discharge practices.
  • While hospitals typically implemented common (and low resource) discharge practices such as providing a list of crisis resources and making referrals, many of the recommended and more robust suicide prevention practices had not yet been widely implemented.
  • Very few hospitals (4%) met full criteria for implementing all four recommended suicide prevention activities at time of discharge.

A native iOS App for First Responders: ESO Unveils Exciting Addition to Electronic Health Record Offering

Retrieved on: 
Tuesday, April 2, 2024

This addition to ESO's suite of offerings is poised to change the user experience for first responders.

Key Points: 
  • This addition to ESO's suite of offerings is poised to change the user experience for first responders.
  • The iOS app, slated for release this winter, will complement ESO's existing EHR Web and EHR Windows Mobile products, providing users with a seamless and intuitive interface for Apple iOS devices.
  • In an evolving landscape where market trends and customer demographics continually shift, ESO remains committed to staying ahead of the curve.
  • The decision to develop a native iOS app stems from a strategic initiative to meet the growing demand for more user-friendly, cost-effective, and versatile solutions in the field.

HCA Healthcare Releases 2024 Annual Impact Report

Retrieved on: 
Thursday, March 28, 2024

HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced the release of its annual Impact Report that reflects on the past year and highlights HCA Healthcare’s positive impact across the communities it serves.

Key Points: 
  • HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced the release of its annual Impact Report that reflects on the past year and highlights HCA Healthcare’s positive impact across the communities it serves.
  • “At HCA Healthcare, our purpose is clear: We exist to give people a healthier tomorrow,” said Sam Hazen, CEO of HCA Healthcare.
  • Last year, 32 HCA Healthcare hospitals were recognized on the Fortune/PINC AI 100 Top Hospitals list, and in early 2024, 54 HCA Healthcare hospitals were included on Healthgrades’ 250 Best Hospitals list for clinical excellence.
  • For more information about the annual HCA Healthcare Impact Report, visit HCAhealthcareImpact.com .